During the conference, Mr. Bancel said Moderna will not seek FDA approval to use the vaccine in the general population until at least late January. He also told the Financial Times the drugmaker won’t seek emergency use authorization for front-line employees until at least Nov. 25.
On that application timeline, an FDA approval that deems Moderna’s vaccine safe and effective for use in the general population probably won’t come until at least late March or early April, according to CBS News.
More articles on pharmacy:
7 former FDA commissioners write opinion column lamenting White House’s treatment of agency
Pfizer’s generics arm partners with online pharmacy Ro
Drug costs aren’t the main reason US spends so much on healthcare, study finds
